IL1B, interleukin 1 beta, 3553

N. diseases: 1801; N. variants: 22
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 Biomarker disease BEFREE Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis. 30977354 2019
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE Our results show that microglia in the spinal cord presented increased M1 polarization and decreased M2 polarization, while overproduction of IL-1β and inhibited expression of IL-10 was detected during bone cancer pain development. 29882480 2018
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE IL-1β-induced NF-κB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1. 28926924 2017
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE Furthermore, administration of berberine is capable of reducing the expression of caspase-1 and IL-1β in osteosarcoma cells and inhibiting the growth of tumor cells. 28000894 2017
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 Biomarker disease BEFREE Hence, the regulation of IL-1β/NF-κB/miR-376c/TGFA signaling in OS might present a promising strategy for the treatment of OS. 29441940 2017
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 GeneticVariation disease BEFREE The aim of this study was to investigate the association between IL-1B gene polymorphisms and osteosarcoma risk in Chinese Han patients. 24878968 2014
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE Tumor necrosis factor-α, interleukin-1β and LPS enhanced osteosarcoma U2OS MMP-9 secretion but had no effect on MMP-2 secretion. 24190483 2014
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE We examined the effect of IL-1 on FGF-2 mRNA and protein expression in human osteosarcoma MG-63 osteoblasts, normal human osteoblasts (NHOB), and osteoblasts from osteoarthritic patients (F2 and F13). 11485304 2001
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 Biomarker disease BEFREE In this study we analyzed the effects of IL-1 on the intracellular distribution of PI3-kinase in wild-type Saos-2 human osteosarcoma cells, and in cell clones overexpressing type I IL-1 receptor (IL-1RI). 9973598 1999
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE This study examines the effects of IL-1 on PGHS-2 mRNA expression in human osteosarcoma MG-63 cells, the human osteoblast-like initial transfectant (HOBIT) cell line, and primary human osteoblastic (HOB) cells. 9661070 1998
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 Biomarker disease BEFREE Recombinant human IL-1 beta inhibits human osteosarcoma cell proliferation, stimulates integrin expression, and induces alkaline phosphatase activity, a marker of osteoinductive and osteoblastic phenotype. 2786815 1989
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 AlteredExpression disease BEFREE These data indicate that the beta 1 integrin family of cell surface receptors is a target for regulation by IL-1 beta, which also regulates cell proliferation and the expression of the osteoblastic phenotype in human osteosarcoma cells. 2521862 1989
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.100 Biomarker disease BEFREE A factor that promotes the growth of certain B cell hybridomas and of plasmacytomas is shown to be produced by normal human fibroblasts and by a line of human osteosarcoma cells (MG-63) after treatment with IL-1 or TNF. 3493322 1987